000 01886 a2200529 4500
005 20250517060806.0
264 0 _c20161018
008 201610s 0 0 eng d
022 _a1538-8514
024 7 _a10.1158/1535-7163.MCT-15-0063
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCesca, Marta
245 0 0 _aBevacizumab-Induced Inhibition of Angiogenesis Promotes a More Homogeneous Intratumoral Distribution of Paclitaxel, Improving the Antitumor Response.
_h[electronic resource]
260 _bMolecular cancer therapeutics
_cJan 2016
300 _a125-35 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAngiogenesis Inhibitors
_xadministration & dosage
650 0 4 _aAnimals
650 0 4 _aBevacizumab
_xadministration & dosage
650 0 4 _aCell Line, Tumor
650 0 4 _aDisease Models, Animal
650 0 4 _aDrug Synergism
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aMagnetic Resonance Imaging
650 0 4 _aMice
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aPaclitaxel
_xadministration & dosage
650 0 4 _aSpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aMorosi, Lavinia
700 1 _aBerndt, Alexander
700 1 _aFuso Nerini, Ilaria
700 1 _aFrapolli, Roberta
700 1 _aRichter, Petra
700 1 _aDecio, Alessandra
700 1 _aDirsch, Olaf
700 1 _aMicotti, Edoardo
700 1 _aGiordano, Silvia
700 1 _aD'Incalci, Maurizio
700 1 _aDavoli, Enrico
700 1 _aZucchetti, Massimo
700 1 _aGiavazzi, Raffaella
773 0 _tMolecular cancer therapeutics
_gvol. 15
_gno. 1
_gp. 125-35
856 4 0 _uhttps://doi.org/10.1158/1535-7163.MCT-15-0063
_zAvailable from publisher's website
999 _c25380994
_d25380994